Product Name:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

IUPAC Name:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

CAS:90213-66-4
Molecular Formula:C6H3Cl2N3
Purity:98%
Catalog Number:CM103618
Molecular Weight:188.01

Packing Unit Available Stock Price($) Quantity
CM103618-100g in stock ƦNJ
CM103618-500g in stock ȺȺũ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:90213-66-4
Molecular Formula:C6H3Cl2N3
Melting Point:-
Smiles Code:ClC1=NC(Cl)=C2C=CNC2=N1
Density:
Catalog Number:CM103618
Molecular Weight:188.01
Boiling Point:
MDL No:MFCD08059278
Storage:-20°C

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.

Column Infos

Capivasertib
On November 16, FDA approved Capivasertib for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative locally advanced or metastatic breast cancer. Capivasertib is a highly selective inhibitor targeting three AKT subtypes (AKT1/2/3), which can block signals used by cancer cells for division and growth.